Annual CFF
-$5.13 B
+$1.34 B+20.78%
31 December 2023
Summary:
Gilead Sciences annual cash flow from financing activities is currently -$5.13 billion, with the most recent change of +$1.34 billion (+20.78%) on 31 December 2023. During the last 3 years, it has fallen by -$5.89 billion (-765.58%). GILD annual CFF is now -251.05% below its all-time high of $3.39 billion, reached on 31 December 2017.GILD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$1.38 B
+$1.57 B+53.30%
30 September 2024
Summary:
Gilead Sciences quarterly cash flow from financing activities is currently -$1.38 billion, with the most recent change of +$1.57 billion (+53.30%) on 30 September 2024. Over the past year, it has increased by +$140.00 million (+9.22%). GILD quarterly CFF is now -120.76% below its all-time high of $6.64 billion, reached on 30 September 2015.GILD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$6.79 B
+$140.00 M+2.02%
30 September 2024
Summary:
Gilead Sciences TTM cash flow from financing activities is currently -$6.79 billion, with the most recent change of +$140.00 million (+2.02%) on 30 September 2024. Over the past year, it has dropped by -$1.21 billion (-21.72%). GILD TTM CFF is now -247.66% below its all-time high of $4.60 billion, reached on 30 September 2012.GILD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.8% | +9.2% | -21.7% |
| 3 y3 years | -765.6% | +60.9% | +0.2% |
| 5 y5 years | +58.4% | +45.2% | +19.2% |
GILD Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -765.6% | +42.3% | -37.5% | +60.9% | -33.7% | +23.5% |
| 5 y | 5 years | -765.6% | +58.4% | -133.4% | +60.9% | -851.3% | +23.5% |
| alltime | all time | -251.1% | +58.4% | -120.8% | +84.0% | -247.7% | +46.1% |
Gilead Sciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.38 B(-53.3%) | -$6.79 B(-2.0%) |
| June 2024 | - | -$2.95 B(+117.0%) | -$6.93 B(+36.5%) |
| Mar 2024 | - | -$1.36 B(+23.8%) | -$5.08 B(-0.9%) |
| Dec 2023 | -$5.13 B(-20.8%) | -$1.10 B(-27.6%) | -$5.13 B(-8.2%) |
| Sept 2023 | - | -$1.52 B(+38.0%) | -$5.58 B(-9.7%) |
| June 2023 | - | -$1.10 B(-21.7%) | -$6.18 B(+1.6%) |
| Mar 2023 | - | -$1.41 B(-9.5%) | -$6.08 B(-6.0%) |
| Dec 2022 | -$6.47 B(-27.1%) | -$1.55 B(-26.6%) | -$6.47 B(-5.7%) |
| Sept 2022 | - | -$2.12 B(+111.2%) | -$6.86 B(-17.0%) |
| June 2022 | - | -$1.00 B(-44.1%) | -$8.27 B(+0.9%) |
| Mar 2022 | - | -$1.79 B(-7.6%) | -$8.19 B(-7.7%) |
| Dec 2021 | -$8.88 B(-1252.9%) | -$1.94 B(-44.9%) | -$8.88 B(+30.5%) |
| Sept 2021 | - | -$3.53 B(+278.8%) | -$6.80 B(-903.3%) |
| June 2021 | - | -$931.00 M(-62.4%) | $847.00 M(-6.3%) |
| Mar 2021 | - | -$2.48 B(-1990.8%) | $904.00 M(+17.4%) |
| Dec 2020 | $770.00 M(-110.1%) | $131.00 M(-96.8%) | $770.00 M(-399.6%) |
| Sept 2020 | - | $4.12 B(-571.9%) | -$257.00 M(-96.3%) |
| June 2020 | - | -$874.00 M(-66.5%) | -$6.90 B(-12.5%) |
| Mar 2020 | - | -$2.61 B(+191.4%) | -$7.88 B(+3.2%) |
| Dec 2019 | -$7.63 B(-38.0%) | -$896.00 M(-64.4%) | -$7.63 B(-9.2%) |
| Sept 2019 | - | -$2.52 B(+35.4%) | -$8.41 B(-4.4%) |
| June 2019 | - | -$1.86 B(-21.5%) | -$8.79 B(+8.7%) |
| Mar 2019 | - | -$2.37 B(+41.7%) | -$8.09 B(-34.3%) |
| Dec 2018 | -$12.32 B(-463.0%) | -$1.67 B(-42.4%) | -$12.32 B(+68.7%) |
| Sept 2018 | - | -$2.90 B(+151.8%) | -$7.30 B(+227.4%) |
| June 2018 | - | -$1.15 B(-82.5%) | -$2.23 B(+13.9%) |
| Mar 2018 | - | -$6.59 B(-297.0%) | -$1.96 B(-157.7%) |
| Dec 2017 | $3.39 B(-134.9%) | $3.35 B(+54.2%) | $3.39 B(-247.4%) |
| Sept 2017 | - | $2.17 B(-346.6%) | -$2.30 B(+37.4%) |
| June 2017 | - | -$880.00 M(-29.3%) | -$1.68 B(-28.9%) |
| Mar 2017 | - | -$1.24 B(-47.0%) | -$2.36 B(-75.8%) |
| Dec 2016 | -$9.72 B(+65.3%) | -$2.35 B(-183.9%) | -$9.72 B(-17.9%) |
| Sept 2016 | - | $2.80 B(-279.2%) | -$11.84 B(+48.1%) |
| June 2016 | - | -$1.56 B(-81.9%) | -$8.00 B(-32.1%) |
| Mar 2016 | - | -$8.61 B(+92.9%) | -$11.78 B(+100.1%) |
| Dec 2015 | -$5.88 B(+94.5%) | -$4.46 B(-167.2%) | -$5.88 B(+3080.5%) |
| Sept 2015 | - | $6.64 B(-224.4%) | -$185.00 M(-98.5%) |
| June 2015 | - | -$5.34 B(+96.2%) | -$12.60 B(+46.0%) |
| Mar 2015 | - | -$2.72 B(-320.6%) | -$8.63 B(+185.3%) |
| Dec 2014 | -$3.02 B(+18.9%) | $1.23 B(-121.4%) | -$3.02 B(-40.7%) |
| Sept 2014 | - | -$5.77 B(+321.0%) | -$5.10 B(+1760.4%) |
| June 2014 | - | -$1.37 B(-147.5%) | -$274.35 M(-150.9%) |
| Mar 2014 | - | $2.88 B(-441.3%) | $539.00 M(-121.2%) |
| Dec 2013 | -$2.54 B(-551.9%) | -$845.12 M(-10.3%) | -$2.54 B(+15.2%) |
| Sept 2013 | - | -$942.23 M(+69.0%) | -$2.21 B(+40.3%) |
| June 2013 | - | -$557.65 M(+180.2%) | -$1.57 B(+5.5%) |
| Mar 2013 | - | -$199.00 M(-61.0%) | -$1.49 B(-364.9%) |
| Dec 2012 | $563.00 M(-68.1%) | -$510.20 M(+65.9%) | $563.00 M(-87.8%) |
| Sept 2012 | - | -$307.51 M(-35.2%) | $4.60 B(+14.1%) |
| June 2012 | - | -$474.88 M(-125.6%) | $4.03 B(+28.6%) |
| Mar 2012 | - | $1.86 B(-47.4%) | $3.13 B(+77.7%) |
| Dec 2011 | $1.76 B(-231.7%) | $3.53 B(-502.5%) | $1.76 B(-179.3%) |
| Sept 2011 | - | -$876.20 M(-36.1%) | -$2.22 B(+106.6%) |
| June 2011 | - | -$1.37 B(-382.8%) | -$1.08 B(+23.7%) |
| Mar 2011 | - | $485.11 M(-205.5%) | -$869.63 M(-35.0%) |
| Dec 2010 | -$1.34 B(+27.3%) | -$459.66 M(-270.0%) | -$1.34 B(+11.3%) |
| Sept 2010 | - | $270.45 M(-123.2%) | -$1.20 B(-36.6%) |
| June 2010 | - | -$1.17 B(-7370.1%) | -$1.90 B(+113.4%) |
| Mar 2010 | - | $16.03 M(-104.9%) | -$889.66 M(-15.4%) |
| Dec 2009 | -$1.05 B(-28.7%) | -$324.08 M(-23.8%) | -$1.05 B(-20.0%) |
| Sept 2009 | - | -$425.32 M(+172.1%) | -$1.31 B(+28.4%) |
| June 2009 | - | -$156.29 M(+7.2%) | -$1.02 B(+10.0%) |
| Mar 2009 | - | -$145.74 M(-75.2%) | -$930.59 M(-36.9%) |
| Dec 2008 | -$1.47 B | -$586.89 M(+336.4%) | -$1.47 B(+69.0%) |
| Sept 2008 | - | -$134.49 M(+111.9%) | -$872.34 M(+27.6%) |
| June 2008 | - | -$63.47 M(-90.8%) | -$683.70 M(-29.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$689.72 M(-4597.1%) | -$975.24 M(+264.8%) |
| Dec 2007 | -$267.30 M(-141.2%) | $15.34 M(-71.7%) | -$267.30 M(+1.6%) |
| Sept 2007 | - | $54.15 M(-115.3%) | -$263.21 M(-12.9%) |
| June 2007 | - | -$355.01 M(-2048.6%) | -$302.30 M(-147.0%) |
| Mar 2007 | - | $18.22 M(-6.2%) | $642.70 M(-1.0%) |
| Dec 2006 | $649.26 M(+46.9%) | $19.43 M(+29.0%) | $649.26 M(-32.7%) |
| Sept 2006 | - | $15.06 M(-97.4%) | $964.74 M(-1.5%) |
| June 2006 | - | $590.00 M(+2281.2%) | $979.57 M(+117.9%) |
| Mar 2006 | - | $24.78 M(-92.6%) | $449.52 M(+1.7%) |
| Dec 2005 | $441.90 M(+461.8%) | $334.90 M(+1020.6%) | $441.90 M(+241.7%) |
| Sept 2005 | - | $29.89 M(-50.2%) | $129.33 M(+11.4%) |
| June 2005 | - | $59.95 M(+249.6%) | $116.07 M(+36.7%) |
| Mar 2005 | - | $17.15 M(-23.2%) | $84.92 M(+8.0%) |
| Dec 2004 | $78.66 M(-4.2%) | $22.34 M(+34.4%) | $78.66 M(+12.2%) |
| Sept 2004 | - | $16.62 M(-42.3%) | $70.13 M(-4.9%) |
| June 2004 | - | $28.80 M(+164.3%) | $73.72 M(+7.8%) |
| Mar 2004 | - | $10.89 M(-21.1%) | $68.39 M(-16.7%) |
| Dec 2003 | $82.09 M(-78.8%) | $13.81 M(-31.7%) | $82.09 M(-80.4%) |
| Sept 2003 | - | $20.22 M(-13.8%) | $417.85 M(+3.1%) |
| June 2003 | - | $23.46 M(-4.6%) | $405.32 M(+3.0%) |
| Mar 2003 | - | $24.60 M(-93.0%) | $393.42 M(+1.8%) |
| Dec 2002 | $386.61 M(+1052.3%) | $349.57 M(+4443.4%) | $386.61 M(+619.2%) |
| Sept 2002 | - | $7.69 M(-33.4%) | $53.76 M(+8.0%) |
| June 2002 | - | $11.56 M(-35.0%) | $49.78 M(-0.3%) |
| Mar 2002 | - | $17.79 M(+6.4%) | $49.91 M(+48.8%) |
| Dec 2001 | $33.55 M(-87.5%) | $16.72 M(+349.4%) | $33.55 M(-87.2%) |
| Sept 2001 | - | $3.72 M(-68.2%) | $261.77 M(-2.6%) |
| June 2001 | - | $11.69 M(+721.4%) | $268.78 M(+2.8%) |
| Mar 2001 | - | $1.42 M(-99.4%) | $261.38 M(-2.8%) |
| Dec 2000 | $269.05 M(+1021.0%) | $244.94 M(+2184.0%) | $269.05 M(+896.3%) |
| Sept 2000 | - | $10.72 M(+149.5%) | $27.00 M(+8.5%) |
| June 2000 | - | $4.30 M(-52.7%) | $24.89 M(+2.6%) |
| Mar 2000 | - | $9.08 M(+213.2%) | $24.27 M(+1.1%) |
| Dec 1999 | $24.00 M(+83.2%) | $2.90 M(-66.3%) | $24.00 M(+3.4%) |
| Sept 1999 | - | $8.61 M(+134.1%) | $23.20 M(+7.9%) |
| June 1999 | - | $3.68 M(-58.3%) | $21.49 M(+2.3%) |
| Mar 1999 | - | $8.82 M(+319.8%) | $21.02 M(+60.4%) |
| Dec 1998 | $13.10 M(-88.3%) | $2.10 M(-69.6%) | $13.10 M(-82.9%) |
| Sept 1998 | - | $6.90 M(+115.6%) | $76.70 M(+3.6%) |
| June 1998 | - | $3.20 M(+255.6%) | $74.00 M(-33.9%) |
| Mar 1998 | - | $900.00 K(-98.6%) | $112.00 M(-0.4%) |
| Dec 1997 | $112.40 M(-30.0%) | $65.70 M(+1464.3%) | $112.40 M(+122.6%) |
| Sept 1997 | - | $4.20 M(-89.8%) | $50.50 M(+9.5%) |
| June 1997 | - | $41.20 M(+3069.2%) | $46.10 M(+738.2%) |
| Mar 1997 | - | $1.30 M(-65.8%) | $5.50 M(-96.6%) |
| Dec 1996 | $160.60 M(+78.4%) | $3.80 M(-2000.0%) | $160.60 M(+2.4%) |
| Sept 1996 | - | -$200.00 K(-133.3%) | $156.80 M(-36.2%) |
| June 1996 | - | $600.00 K(-99.6%) | $245.90 M(+0.1%) |
| Mar 1996 | - | $156.40 M(+75.9%) | $245.70 M(+177.0%) |
| Dec 1995 | $90.00 M(+1566.7%) | - | - |
| Sept 1995 | - | $88.90 M(>+9900.0%) | $88.70 M(<-9900.0%) |
| June 1995 | - | $400.00 K(-166.7%) | -$600.00 K(-111.1%) |
| Mar 1995 | - | -$600.00 K(<-9900.0%) | $5.40 M(-5.3%) |
| Mar 1995 | $5.40 M(+350.0%) | - | - |
| Dec 1994 | - | $0.00(-100.0%) | $5.70 M(-13.6%) |
| Sept 1994 | - | -$400.00 K(-106.3%) | $6.60 M(-10.8%) |
| June 1994 | - | $6.40 M(-2233.3%) | $7.40 M(+516.7%) |
| Mar 1994 | $1.20 M(-97.5%) | -$300.00 K(-133.3%) | $1.20 M(-84.2%) |
| Dec 1993 | - | $900.00 K(+125.0%) | $7.60 M(-84.0%) |
| Sept 1993 | - | $400.00 K(+100.0%) | $47.50 M(0.0%) |
| June 1993 | - | $200.00 K(-96.7%) | $47.50 M(+0.6%) |
| Mar 1993 | $47.20 M(-52.5%) | $6.10 M(-85.0%) | $47.20 M(+14.8%) |
| Dec 1992 | - | $40.80 M(>+9900.0%) | $41.10 M(>+9900.0%) |
| Sept 1992 | - | $400.00 K(-500.0%) | $300.00 K(-400.0%) |
| June 1992 | - | -$100.00 K | -$100.00 K |
| Mar 1992 | $99.30 M(+1189.6%) | - | - |
| Mar 1991 | $7.70 M | - | - |
FAQ
- What is Gilead Sciences annual cash flow from financing activities?
- What is the all time high annual CFF for Gilead Sciences?
- What is Gilead Sciences annual CFF year-on-year change?
- What is Gilead Sciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Gilead Sciences?
- What is Gilead Sciences quarterly CFF year-on-year change?
- What is Gilead Sciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Gilead Sciences?
- What is Gilead Sciences TTM CFF year-on-year change?
What is Gilead Sciences annual cash flow from financing activities?
The current annual CFF of GILD is -$5.13 B
What is the all time high annual CFF for Gilead Sciences?
Gilead Sciences all-time high annual cash flow from financing activities is $3.39 B
What is Gilead Sciences annual CFF year-on-year change?
Over the past year, GILD annual cash flow from financing activities has changed by +$1.34 B (+20.78%)
What is Gilead Sciences quarterly cash flow from financing activities?
The current quarterly CFF of GILD is -$1.38 B
What is the all time high quarterly CFF for Gilead Sciences?
Gilead Sciences all-time high quarterly cash flow from financing activities is $6.64 B
What is Gilead Sciences quarterly CFF year-on-year change?
Over the past year, GILD quarterly cash flow from financing activities has changed by +$140.00 M (+9.22%)
What is Gilead Sciences TTM cash flow from financing activities?
The current TTM CFF of GILD is -$6.79 B
What is the all time high TTM CFF for Gilead Sciences?
Gilead Sciences all-time high TTM cash flow from financing activities is $4.60 B
What is Gilead Sciences TTM CFF year-on-year change?
Over the past year, GILD TTM cash flow from financing activities has changed by -$1.21 B (-21.72%)